NOTE 4 - CAPITAL STOCK | During the years ended December 31, 2017 and 2016, the Company did not issue any shares of its common stock. Capitalization The authorized capital of the Company is 500,000,000 shares of capital stock, divided into 480,000,000 shares of common stock with a par value of $0.001 per share, and 20,000,000 shares of preferred stock with a par value of $0.001 per share. The Company reserved 10,000,000 shares of common stock for issuance under its 2016 Omnibus Equity Incentive Plan. No preferred shares have been issued to December 31, 2017 or to the date of issue of these financial statements. Options On February 14, 2017, the Company granted 9,500,000 non-qualified stock options pursuant to the Equity Incentive Plan, to key corporate officers and outside consultants, with 25% vesting immediately and a further 25% vesting every six months thereafter for eighteen months. Each option is exercisable into one share of the Company’s common stock at a price of $0.06 per share, equal to the closing price of the common stock on the grant date, for a term of five years. The options had an estimated fair value of $509,702 at December 31, 2017. For the year ended December 31, 2017, $442,808 has been included in consulting services expense, based on fair value estimates determined using the Black-Scholes option pricing model with an average risk-free rate of 1.98%, a weighted average life of 4.88 years, volatility of 193.66% and dividend yield of 0%. The valuation used average weekly pricing. At December 31, 2017, the options had an intrinsic value of $0 based on the exercise price of $0.06 per option and a market price of $0.032 per share. A summary of option activity in the current year and options outstanding at December 31, 2017 is as follows: Options Issued Vested Exercise Price Weighted Average Exercise Price Weighted Average Life Remaining (Years) Expiry Date Intrinsic Value Balance December 31, 2016 — — — — — — — Issued 9,500,000 4,750,000 $ 0.06 $ 0.06 5.00 February 14, 2022 — Expired — — — — — — — Exercised — — — — — — — Balance December 31, 2017 9,500,000 4,750,000 $ 0.06 $ 0.06 4.12 February 14, 2022 — Warrants During the years ended December 31, 2017 and 2016, no warrants to purchase shares of common stock were issued and no warrants were exercised. At December 31, 2017, warrants issued in 2015 had an intrinsic value of $40,033 based on the exercise price of $0.02 per warrant and a market price of $0.032 per share. A summary of warrant activity and warrants outstanding at December 31, 2017 and 2016 is as follows: Number of Warrants Exercise Price Weighted Average Exercise Price Weighted Average Life Remaining (Years) Expiry Date Intrinsic Value Balance December 31, 2015 3,336,060 $ 0.02 $ 0.02 4.86 November 19, 2020 $33,361 Issued — — — — — — Expired — — — — — — Exercised — — — — — — Balance December 31, 2016 3,336,060 $ 0.02 $ 0.02 3.86 November 19, 2020 $66,721 Issued — — — — — — Expired — — — — — — Exercised — — — — — — Balance outstanding and exercisable at December 31, 2017 3,336,060 $ 0.02 $ 0.02 2.86 November 19, 2020 $40,033 |